logo
  

Takeda Reaches Agreement With JCR Pharma To Commercialize JR-141 Outside Of U.S.

Takeda Pharmaceutical Company Limited (TKPHF.PK,TAK) and JCR Pharmaceuticals Co., Ltd. have entered a collaboration and license agreement to commercialize JR-141, an investigational, next-generation recombinant fusion protein of an antibody against the human transferrin receptor and iduronate-2-sulfatase enzyme for the treatment of Hunter syndrome. Under the agreement, Takeda will exclusively commercialize JR-141 outside of the United States, including Canada, Europe, and other regions (excluding Japan and certain other Asia-Pacific countries).

JCR will receive an upfront payment for the ex-U.S. license, and is eligible to receive additional development and commercial milestones as well as tiered royalties on potential sales.

Takeda also received an option under a separate option agreement, which allows it to acquire an exclusive license to commercialize JR-141 in the U.S. upon completion of the phase 3 program.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Aerospace giant Boeing Co. (BA) on Wednesday reported fourth-quarter net loss attributable to Boeing shareholders of $4.16 billion or $7.02 per share, sharply narrower than $8.44 billion or $14.65 per share in the year-ago quarter. The 787 program recorded $3.5 billion pre-tax non-cash charge; focused... Telecom giant AT&T reported Wednesday a profit for the fourth quarter compared to a loss last year, primarily boosted by continuing customer growth in wireless, fiber and HBO Max, despite a 10 percent drop in revenues. Both adjusted earnings for the quarter and quarterly revenues also topped analysts' expectations. However, the company issued weak earnings and sales growth outlook for fiscal 2022. Bentley Motors, owned by German automaker Volkswagen AG, announced plans to develop its first-ever Battery-Powered Electric Vehicle or BEV in 2025. The British luxury carmaker also plans investment of around 2.5 billion pounds or $3.4 billion in sustainability over the next ten years. The company will develop and build the new vehicles in the UK plant in Crewe.
RELATED NEWS
Follow RTT